The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing

Avraham Beigelman; Robert S. Zeiger; David Mauger; Robert C. Strunk; Daniel J. Jackson; Fernando D. Martinez; Wayne J. Morgan; Ronina Covar; Stanley J. Szefler; Lynn M. Taussig; Leonard B. Bacharier

doi:10.1016/j.jaci.2014.02.024

The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing

Avraham Beigelman, Robert S. Zeiger, David Mauger, Robert C. Strunk, Daniel J. Jackson, Fernando D. Martinez, Wayne J. Morgan, Ronina Covar, Stanley J. Szefler, Lynn M. Taussig, Leonard B. Bacharier

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Original language	English (US)
Pages (from-to)	1489-1492.e3
Journal	Journal of Allergy and Clinical Immunology
Volume	133
Issue number	5
DOIs	https://doi.org/10.1016/j.jaci.2014.02.024
State	Published - May 2014

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2014.02.024

Cite this

Beigelman, A., Zeiger, R. S., Mauger, D., Strunk, R. C., Jackson, D. J., Martinez, F. D., Morgan, W. J., Covar, R., Szefler, S. J., Taussig, L. M., & Bacharier, L. B. (2014). The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing. Journal of Allergy and Clinical Immunology, 133(5), 1489-1492.e3. https://doi.org/10.1016/j.jaci.2014.02.024

The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing. / Beigelman, Avraham; Zeiger, Robert S.; Mauger, David; Strunk, Robert C.; Jackson, Daniel J.; Martinez, Fernando D.; Morgan, Wayne J.; Covar, Ronina; Szefler, Stanley J.; Taussig, Lynn M.; Bacharier, Leonard B.

In: Journal of Allergy and Clinical Immunology, Vol. 133, No. 5, 05.2014, p. 1489-1492.e3.

Research output: Contribution to journal › Article › peer-review

Beigelman, A, Zeiger, RS, Mauger, D, Strunk, RC, Jackson, DJ, Martinez, FD , Morgan, WJ, Covar, R, Szefler, SJ, Taussig, LM & Bacharier, LB 2014, 'The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing', Journal of Allergy and Clinical Immunology, vol. 133, no. 5, pp. 1489-1492.e3. https://doi.org/10.1016/j.jaci.2014.02.024

Beigelman, Avraham ; Zeiger, Robert S. ; Mauger, David ; Strunk, Robert C. ; Jackson, Daniel J. ; Martinez, Fernando D. ; Morgan, Wayne J. ; Covar, Ronina ; Szefler, Stanley J. ; Taussig, Lynn M. ; Bacharier, Leonard B. / The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing. In: Journal of Allergy and Clinical Immunology. 2014 ; Vol. 133, No. 5. pp. 1489-1492.e3.

@article{66a9ad40176c4c0d9eb42cf1b095b8ee,

title = "The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing",

author = "Avraham Beigelman and Zeiger, {Robert S.} and David Mauger and Strunk, {Robert C.} and Jackson, {Daniel J.} and Martinez, {Fernando D.} and Morgan, {Wayne J.} and Ronina Covar and Szefler, {Stanley J.} and Taussig, {Lynn M.} and Bacharier, {Leonard B.}",

note = "Funding Information: This study was supported by the National Heart, Lung, and Blood Institute (grants 5U10HL064287 , 5U10HL064288 , 5U10HL064295 , 5U10HL064307 , 5U10HL064305 , and 5U10HL064313 ). This study is supported in part by the Washington University Institute of Clinical and Translational Sciences (grant no. UL1 TR000448 ), the National Center for Advancing Translational Sciences (subaward no. KL2 TR000450 ), the University of Wisconsin School of Medicine and Public Health Clinical and Translational Science Award (CTSA) (grant no. UL1 TR000427 ), and Colorado CTSA (grant no. 1 UL1RR025780 from the National Center for Research Resources/National Institutes of Health). This study was carried out in part in the General Clinical Research Centers at Washington University School of Medicine ( M01 RR00036 ), at National Jewish Health ( M01 RR00051 ), and at the University of New Mexico ( M01 RR00997 ). Funding Information: Disclosure of potential conflict of interest: A. Beigelman has received grants from the National Heart, Lung, and Blood Institute (NHLBI) , the KL2 Award , and Washington University's ICTS award and is employed by the Washington University School of Medicine. R. S. Zeiger has received grants from the NHLBI , Genentech , GlaxoSmithKline , Aerocrine , Merck , MedImmune , and Thermofisher and has consultant arrangements with Aerocrine, AstraZeneca, Genentech, GlaxoSmithKline, MedImmune, Schering Plough, Sunovion, and the NHLBI/Penn State. D. Mauger has received a grant from the NHLBI ; has received payment for providing writing assistance, medicines, equipment, or administrative support from AstraZeneca; and has consultant arrangements with GlaxoSmithKline, Boerhinger Ingelheim, and Merck. R. C. Strunk has received a grant from the NHLBI . D. J. Jackson has received grants from the National Institutes of Health (NIH) and Pharmaxis and has consultant arrangements with Gilead and GlaxoSmithKline. F. D. Martinez has received a grant from the NIH ; has consultant arrangements with MedImmune; has received payment for lectures from Abbott and Merck; and has received travel support from Abbott and Merck. W. J. Morgan has received grants from the NHLBI , the Cystic Fibrosis Foundation , and the National Institute of Allergy and Infectious Disease ; has consultant arrangements with the Cystic Fibrosis Foundation and Genentech; is employed by the University of Arizona; has received payment for lectures from Northwestern University, Indiana University, and St Jude's; and has received royalties from Elsevier. R. Covar has received grants from the NHLBI, GlaxoSmithKline, and Boehringer Ingelheim and has consultant arrangements with United Biosource. S. J. Szefler has received a grant, travel support, fees for participation in review activities, and payment for writing/reviewing the manuscript from the NHLBI; has consultant arrangements with Merck, Genentech, Boehringer Ingelheim, and GlaxoSmithKline; has received a grant from GlaxoSmithKline ; has received payment for lectures from Merck; has received payment for manuscript preparation from Genentech; and has patents planned through the NHLBI Childhood Asthma Research and Education Network. L. B. Bacharier has received grants from the NHLBI ; has consultant arrangements with Aerocrine, GlaxoSmithKline, Genentech/Novartis, Merck, Schering, Cephalon, and DBV; has received payment for lectures from Aerocrine, AstraZeneca, Genentech, GlaxoSmithKline, Merck, and Schering; and has received payment for manuscript preparation from First Consult. L. Taussig declares no relevant conflicts of interest. ",

year = "2014",

month = may,

doi = "10.1016/j.jaci.2014.02.024",

language = "English (US)",

volume = "133",

pages = "1489--1492.e3",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing

AU - Beigelman, Avraham

AU - Zeiger, Robert S.

AU - Mauger, David

AU - Strunk, Robert C.

AU - Jackson, Daniel J.

AU - Martinez, Fernando D.

AU - Morgan, Wayne J.

AU - Covar, Ronina

AU - Szefler, Stanley J.

AU - Taussig, Lynn M.

AU - Bacharier, Leonard B.

N1 - Funding Information: This study was supported by the National Heart, Lung, and Blood Institute (grants 5U10HL064287 , 5U10HL064288 , 5U10HL064295 , 5U10HL064307 , 5U10HL064305 , and 5U10HL064313 ). This study is supported in part by the Washington University Institute of Clinical and Translational Sciences (grant no. UL1 TR000448 ), the National Center for Advancing Translational Sciences (subaward no. KL2 TR000450 ), the University of Wisconsin School of Medicine and Public Health Clinical and Translational Science Award (CTSA) (grant no. UL1 TR000427 ), and Colorado CTSA (grant no. 1 UL1RR025780 from the National Center for Research Resources/National Institutes of Health). This study was carried out in part in the General Clinical Research Centers at Washington University School of Medicine ( M01 RR00036 ), at National Jewish Health ( M01 RR00051 ), and at the University of New Mexico ( M01 RR00997 ). Funding Information: Disclosure of potential conflict of interest: A. Beigelman has received grants from the National Heart, Lung, and Blood Institute (NHLBI) , the KL2 Award , and Washington University's ICTS award and is employed by the Washington University School of Medicine. R. S. Zeiger has received grants from the NHLBI , Genentech , GlaxoSmithKline , Aerocrine , Merck , MedImmune , and Thermofisher and has consultant arrangements with Aerocrine, AstraZeneca, Genentech, GlaxoSmithKline, MedImmune, Schering Plough, Sunovion, and the NHLBI/Penn State. D. Mauger has received a grant from the NHLBI ; has received payment for providing writing assistance, medicines, equipment, or administrative support from AstraZeneca; and has consultant arrangements with GlaxoSmithKline, Boerhinger Ingelheim, and Merck. R. C. Strunk has received a grant from the NHLBI . D. J. Jackson has received grants from the National Institutes of Health (NIH) and Pharmaxis and has consultant arrangements with Gilead and GlaxoSmithKline. F. D. Martinez has received a grant from the NIH ; has consultant arrangements with MedImmune; has received payment for lectures from Abbott and Merck; and has received travel support from Abbott and Merck. W. J. Morgan has received grants from the NHLBI , the Cystic Fibrosis Foundation , and the National Institute of Allergy and Infectious Disease ; has consultant arrangements with the Cystic Fibrosis Foundation and Genentech; is employed by the University of Arizona; has received payment for lectures from Northwestern University, Indiana University, and St Jude's; and has received royalties from Elsevier. R. Covar has received grants from the NHLBI, GlaxoSmithKline, and Boehringer Ingelheim and has consultant arrangements with United Biosource. S. J. Szefler has received a grant, travel support, fees for participation in review activities, and payment for writing/reviewing the manuscript from the NHLBI; has consultant arrangements with Merck, Genentech, Boehringer Ingelheim, and GlaxoSmithKline; has received a grant from GlaxoSmithKline ; has received payment for lectures from Merck; has received payment for manuscript preparation from Genentech; and has patents planned through the NHLBI Childhood Asthma Research and Education Network. L. B. Bacharier has received grants from the NHLBI ; has consultant arrangements with Aerocrine, GlaxoSmithKline, Genentech/Novartis, Merck, Schering, Cephalon, and DBV; has received payment for lectures from Aerocrine, AstraZeneca, Genentech, GlaxoSmithKline, Merck, and Schering; and has received payment for manuscript preparation from First Consult. L. Taussig declares no relevant conflicts of interest.

PY - 2014/5

Y1 - 2014/5

UR - http://www.scopus.com/inward/record.url?scp=84899642811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899642811&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2014.02.024

DO - 10.1016/j.jaci.2014.02.024

M3 - Article

C2 - 24698320

AN - SCOPUS:84899642811

VL - 133

SP - 1489-1492.e3

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 5

ER -

The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this